Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by Engcan77on Sep 18, 2019 9:31pm

134 Views

Post# 30141663

RE:RE:RE:RE:Stock looks weak

We,ve been waiting years for the first deal for the TFC-1067,and now its finally completed!! What a big relief. I am thrilled that this is just the beginning of many deals ahead for the skin lightener. Plus major developments in other areas. Not too happy we didn't see the numbers today, however we could very well see other deals before seeing the financials on this one. R+F may have got a better deal seeing there will be future partnerships in other products.
Some will have negative comments no matter what news comes out...it's just the way it is. No need to get pissed off...it's just the way it is.
Looking forward to the next news releases, that i think will be coming thick and fast :)

Bullboard Posts

Calibre discovers significant gold in Newfoundland